Norofert, the leading producer of organic agricultural inputs and biotechnology provider for agriculture in Romania, listed on the AeRO market of the Bucharest Stock Exchange, recorded a net profit of 4.5 million RON in the first nine months of 2025, up 227 percent, supported by cost efficiency, the performance of the Zimnicea farm that benefited from favorable weather at the beginning of the year, and the results generated by the company in the United States.

Revenues reached 29 million RON, being 18 percent lower than in the same period last year, reflecting lower volumes in the domestic market and a prudent commercial strategy focused on high value projects.

Vlad Popescu, President of the Board, Norofert: “In a year with significant challenges for the entire agribusiness sector, Norofert acted with prudence and focused on its core activity – production and commercialization of bacteria-based solutions developed in the Filipeștii de Pădure laboratory. Also, this year, we advanced with the investments in irrigation and in the factory in Brazil, and in October we reached a new stage in international expansion with the official launch of the facility. In the United States, the revenues already account for approximatively 10 percent of the revenue recorded in the first nine months of 2025. On the medium-term, the main goal is to strengthen our presence in the United States and Brazil. These markets could generate up to 40 percent of the group revenues in the next three years. Our ambition is for Norofert to become a representative of Romanian innovation in international agriculture, in close partnership with the capital market.” 

The new production facility in Chapeco, Brazil, developed in partnership with the Engenutri Group, became operational in October. The facility has a capacity of 15,000 liters per day and uses bacteria produced in the Filipeștii de Pădure research laboratory, a center of excellence for agricultural biotechnology and the core of the company research activities.